Skip to main content
Article
131I-Tositumomab Consolidation Radioimmunotherapy (RIT) In Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Lymphoma (SLL) In First Remission
Blood (2013)
  • Ajay K. Gopal, University of Washington
  • Pamela S. Becker, University of Washington
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Barbara Pender, Fred Hutchinson Cancer Research Center
  • Andrei R. Shustov, University of Washington
  • Raya Mawad, University of Washington
  • Britt Kammerer, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Publication Date
November 15, 2013
Citation Information
Ajay K. Gopal, Pamela S. Becker, David G. Maloney, Barbara Pender, et al.. "131I-Tositumomab Consolidation Radioimmunotherapy (RIT) In Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Lymphoma (SLL) In First Remission" Blood Vol. 122 Iss. 21 (2013) p. 1644 - 1644
Available at: http://works.bepress.com/john-pagel/124/